Sei Investments Co. Has $2.97 Million Stock Holdings in Masimo Co. (NASDAQ:MASI)

Sei Investments Co. reduced its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 75.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,594 shares of the medical equipment provider's stock after selling 72,048 shares during the quarter. Sei Investments Co.'s holdings in Masimo were worth $2,971,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Riverview Trust Co bought a new stake in Masimo in the first quarter valued at about $25,000. GAMMA Investing LLC boosted its stake in Masimo by 75.0% during the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider's stock worth $33,000 after acquiring an additional 111 shares during the last quarter. Parallel Advisors LLC grew its holdings in Masimo by 48.3% during the fourth quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider's stock valued at $52,000 after purchasing an additional 145 shares during the period. HHM Wealth Advisors LLC increased its stake in Masimo by 25.0% in the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider's stock valued at $79,000 after purchasing an additional 125 shares in the last quarter. Finally, Lazard Asset Management LLC raised its holdings in Masimo by 5,730.0% in the first quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider's stock worth $85,000 after purchasing an additional 573 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Up 4.8 %

NASDAQ MASI traded up $6.41 on Friday, reaching $138.83. The company had a trading volume of 2,475,412 shares, compared to its average volume of 675,481. The company's fifty day moving average is $119.19 and its 200-day moving average is $125.05. Masimo Co. has a 1-year low of $75.22 and a 1-year high of $153.93. The firm has a market capitalization of $7.38 billion, a price-to-earnings ratio of 94.44 and a beta of 0.99. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15 and a current ratio of 2.09.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.77 by $0.09. The business had revenue of $496.30 million during the quarter, compared to the consensus estimate of $493.92 million. Masimo had a return on equity of 14.07% and a net margin of 3.94%. Masimo's quarterly revenue was up 9.0% on a year-over-year basis. During the same period last year, the company earned $0.62 earnings per share. On average, research analysts forecast that Masimo Co. will post 3.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on MASI shares. Piper Sandler upped their price objective on shares of Masimo from $160.00 to $165.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research note on Friday, September 20th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $144.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.